CAPRICOR THERAPEUTICS, INC. Accounts Payable
CAPRICOR THERAPEUTICS, INC. (CAPR) had Accounts Payable of $3.08 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $3.08M.
- 2026-03-31: Accounts Payable, Current $3.93M.
- 2025-12-31: Accounts Payable, Current $1.65M.
- 2025-09-30: Accounts Payable, Current $2.72M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.08M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.93M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.65M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.72M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $4.81M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.25M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $3.28M 10-K · filed 2026-03-17 |
| 2013-09-30 | $339.25K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $397.58K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $249.35K 10-Q · filed 2013-06-21 |
| 2012-12-31 | $182.92K 10-Q · filed 2013-11-14 |
| 2012-09-30 | $210.05K 10-Q · filed 2013-06-21 |
| 2012-06-30 | $121.72K 10-Q/A · filed 2012-09-10 |
| 2012-03-31 | $327.15K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $437.84K 10-Q · filed 2013-06-21 |
| 2011-09-30 | $504.33K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $237.76K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $332.38K 10-K · filed 2012-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |